Health care challenge is helping consumers manage their health
MELBOURNE: The new health care challenge is helping consumers manage their health outcomes.
A conference today heard from seven experts.
CVS Health CEO Larry Merlo said he believes the era of massive consolidation in health care is “probably behind us.”
Merlo and CVS have been leaders in that effort, culminating in the drugstore chain’s $69 billion acquisition of health insurer Aetna almost a year ago.
“The lines are beginning to blur between being competitors and business partners,” Merlo said during a conversation Sunday with U.S. News Editorial Director Brian Kelly at the company’s Healthcare of Tomorrow event in Washington, D.C.
Merlo, who began his career in Washington as a pharmacist at Peoples Drugs, said the new version of the corner drugstore is much like the old one, absent the soda counter. “The role of the pharmacist — being part of the community — that hasn’t changed, ” he said.
Now, though, the pharmacist is using technology and advanced data analytics to reach customers and patients, often offering services that are complementary, or in place of, the local physician. At the company’s MinuteClinics, for example, half of the visits occur at night or on weekends — and half of those who show up do not have a primary care physician. “We can treat about 80% of what a primary care physician can treat.” But, he added, “We’re not just focused on sick care but wellness.”
The Aetna acquisition is already paying off, with CVS reporting third-quarter earnings last week that were 10% better than the same quarter last year, driven in part by Aetna and growth in the CVS retail pharmacy business. (U.S. News produces its Healthiest Communities editorial platform in collaboration with the Aetna Foundation, an independent charitable and philanthropic affiliate of CVS Health.)
Merlo said the company is now focused squarely on the management of its customers’ health problems, noting that many people in America suffer from at least one or two chronic diseases like diabetes or hypertension.
The company has been aggressive in tackling the underlying issues behind America’s health care problems. In 2014, Merlo ended the sale of cigarettes and tobacco products in its stores, saying at the time that “it is simply the right thing to do for the good of our customers and our company.”
Sunday, Merlo said the move energized the company and helped lead it on its current path to becoming “more of a health services company.”
More recently, the company has taken steps to address the epidemic of opioid abuse. It has expanded access to Naloxone, a drug that can reverse the effects of overdoses, increased training and education programs, and supported local addiction and recovery centers through community grants. Working closely with local police departments and with its in-store drug take-back program, “We’ve removed over one million pounds of unused prescriptions,” though that includes other drugs than opioids. CVS also limits first-time opioid prescriptions to a 7-day supply, which he said has sharply curtailed opioid usage.
In a separate panel at the conference, a handful of speakers representing the far-flung corners of the health care industry spoke of the rapid changes affecting their businesses.
Ninfa Saunders, president and CEO of Navicent Health, talked about efforts to reduce inequality in patient care. She described a partnership with a Georgia startup that allowed her nonprofit health system to better monitor patients with diabetes.
Farzad Mostashari, a former health policy worker, told of starting a new company where the business model is “absolutely predicated on taking risk.” Aledade, the company of which Mostashari is CEO, helps doctors transition to value-based payments where they are paid for preventative care rather than on procedures or volumes.






